A two-stage case-control study of EGFR polymorphisms and breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 2, 2009, Pages 680-683

  Hong, Young Seoub ^a,d   Deming, Sandra L ^a   Gao, Yu Tang ^b   Long, Ji Rong ^a   Shu, Xiao Ou ^a   Cai, Qiuyin ^a   Lu, Wei ^c   Zheng, Wei ^a,e  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b SHANGHAI CANCER INSTITUTE   (China)

^c Shanghai Center for Disease Prevention and Control   (China)

^d Dong A University   (South Korea)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CANCER STAGING; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; INCIDENCE; INTERVIEWS AS TOPIC; LOGISTIC MODELS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 60549103889     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0961     Document Type: Article

References (16)

1. O'Driscoll L, Clynes M. Biomarkers and multiple drug resistance in breast cancer. Curr Cancer Drug Targets 2006;6:365-84.
2. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomark Prev 1999;8:843-54.
3. Bianco R, Gelardi T, Damiano V, Ciardello F, Tortora G. Rational bases for the development of EGFR inhibitors for cancer treatment. Int J Biochem Cell Biol 2007;39:1416-31.
4. Merlinov G, Ishii N, Whang PJ, et al. Structure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol Cell Biol 1985;5:1722-34.
5. Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 2000;87:295-300.
6. Beeghly-Fadiel A, Long JR, Zheng W, et al. Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality. Cancer Res 2008;68: 6453-9.
7. The International HapMap Project. Nature 2003;426:789-96.
8. de Bakker PIW, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006;38:1166-72.
9. Hardenbol P, Yu F, Belmont J, et al. Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay. Genome Res 2005;15:269-75.
10. Liu W, Innocenti F, Wu MH, et al. A functional common polymorphism in a Sp 1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res 2005;65:46-53.
11. Carpentier C, Laigle-Donadey F, Marie Y, et al. Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma. Neurology 2006;67:872-4.
12. Choi JE, Park JY, Park SH, et al. Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study. BMC 2007;7:199.
13. Gebhard F, Zanker KS, Brandt B. Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1. J Biol Chem 1999;274:13176-80.
14. Brandt B, Hermann S, Straif K, Tidow N, Buerger H, Chang-Claude J. Modification of breast cancer risk in young women by a polymorphic sequence in the EGFR gene. Cancer Res 2004;64:7-12.
15. Zhang W, Weissfeld JL, Romkes M, Land SR, Grandis JR, Siegfried JM. Association of the EGFR intron 1 CA repeat length with lung cancer risk. Mol Carcinog 2007;46:372-80.
16. Lee SJ, Park JY, Kim KM, et al. No association between dinucleotide repeats polymorphisms in intron 1 of the epidermal growth factor receptor gene EGFR and risk of lung cancer. Cancer Genet Cytogenet 2007;172:29-32.